NCT02241681View on ClinicalTrials.gov

Medium Chain Triglycerides Plasma Profile and Their Metabolites After Oral Peptamen Intake

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

November 30, 2014

Study Completion Date

January 31, 2015

Conditions
Healthy
Interventions
DIETARY_SUPPLEMENT

Peptamen 1.5

Peptamen will be given twice at the dose of 250 mL, with an interval of 4 hours.

Trial Locations (1)

1000

Metabolic unit, clinical Development unit, Nestec, Lausanne

All Listed Sponsors
lead

Société des Produits Nestlé (SPN)

INDUSTRY

NCT02241681 - Medium Chain Triglycerides Plasma Profile and Their Metabolites After Oral Peptamen Intake | Biotech Hunter | Biotech Hunter